DESCRIPTION:
- Few published books on this topic
- Complete coverage of topic
- Contributions by cardiologists and nephrologists
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management. The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions. This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
CONTENTS:
Part One Epidemiology
Chapter 1. Epidemiology of Chronic Kidney Disease in Heart Failure
Chapter 2. Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin?
Part Two Pathophysiology
Chapter 3. Renal Hemodynamic Changes in Heart Failure
Chapter 4. Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade
Chapter 5. Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient
Chapter 6. B-Type Natriuretic Peptide: Beyond Diagnostic Applications
Part Three Management of Kidney Associated Clinical Problems
Chapter 7. Hyperkalemia Risk and Treatment of Heart Failure
Chapter 8. Management of Heart Failure with Renal Artery Ischaemia
Chapter 9. Renal Consequences of Prostaglandin Inhibition in Heart Failure
Chapter 10. Edema Mechanisms in the Heart Failure Patient and Treatment Option
Chapter 11. Ultrafiltration and Heart Failure
Part Four Advances in Nephropathy Management: Influences on CVD Risk
Chapter 12. Combination Therapy in Hypertension Treatment
Chapter 13. Medication Adherence in Heart Failure
Chapter 14. New Markers of Vascular Risk
Chapter 15. Dietary Paradoxes to Optimize CV Risk Management in CKD
